Lung Cancer
From the Journals
Plasma monitoring supports earlier osimertinib treatment in lung cancer patients
More patients met progression-free survival endpoints after shorter stint on gefitinib.
From the Journals
ASCO updates treatment guidelines for anxiety and depression
Since the last guidelines were published, screening and assessment for depression and anxiety have improved, and a large new evidence base has...
From the Journals
New clues to how air pollution fuels lung cancer in nonsmokers
Although smoking remains the chief risk factor for lung cancer, outdoor air pollution causes roughly 1 in 10 cases.
From the Journals
Cancer pain declines with cannabis use
Lower use of other meds was also seen in patients who used cannabis.
From the Journals
First guideline for treating oligometastatic NSCLC
An increasing number of radiation oncologists and multidisciplinary teams are now using local therapy beyond palliative care for these patients....
Conference Coverage
Durvalumab pre, post surgery in NSCLC: Practice changing?
A new study’s findings confirm the benefits of neoadjuvant immunotherapy.
Latest News
Cancer, heart disease vaccines may be ready by 2030, Moderna says
The announcement is yet another sign of what many are calling “the golden age” of vaccine development.
From the Journals
AFib risk with cancer drugs underestimated
Many cancer therapies increase the risk of atrial fibrillation, but this is underreported in clinical trials.
Conference Coverage
Study gives new insight into timing of combo treatment in metastatic NSCLC
Best outcomes came when immunotherapy followed radiotherapy by 1-12 months.
Conference Coverage
Long-term heavy smoking quadruples likelihood of lung cancer vs. less heavy smoking
A new report offers more insight into the connection between cumulative smoking levels and lung cancer.
Conference Coverage
First target doesn’t affect survival in NSCLC with brain metastases
Patient outcomes didn’t hinge on whether oncologists treated the brain or lung first.